Valuation: Karex

Market Cap 406M 99.04M 89.98M 83.14M 75.1M 142M 9.3B 147M 1B 396M 4.99B 372M 364M 15.81B P/E 2027 *
21.4x
P/E 2028 * 12.2x
Enterprise Value 341M 83.39M 75.76M 70M 63.23M 119M 7.83B 124M 842M 334M 4.2B 313M 306M 13.31B EV / Sales 2027 *
0.66x
EV / Sales 2028 * 0.61x
Free-Float
39.68%
Yield 2027 *
2.42%
Yield 2028 * 3.64%
1 day-1.30%
1 week-6.17%
Current month-8.43%
1 month-13.64%
3 months-20.83%
6 months-23.23%
Current year-46.10%
1 week 0.38
Extreme 0.38
0.4
1 month 0.38
Extreme 0.38
0.44
Current year 0.38
Extreme 0.38
0.73
1 year 0.38
Extreme 0.38
0.8
3 years 0.38
Extreme 0.38
1.09
5 years 0.32
Extreme 0.325
1.09
10 years 0.26
Extreme 0.26
2.62
Manager TitleAgeSince
Chief Executive Officer 48 2013-07-28
Director of Finance/CFO 49 2025-06-29
Chief Tech/Sci/R&D Officer 71 2012-09-26
Director TitleAgeSince
Director/Board Member 71 2012-09-26
Director/Board Member 83 2012-11-29
Director/Board Member 48 2020-02-24
Date Insider Type Main position Quantity % Market Cap. Importance
7/16/26 Free

Director

80,000 0.0076%
7/16/26 Free

Chief Technology Officer

80,000 0.0076%
7/16/26 Free

Chief Executive Officer

80,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-6.17%-51.28%-46.10% 99.04M
+1.90%+2.79%+17.17%+13.21% 401B
-0.23%+1.18%+26.67%+5.93% 264B
-0.35%+1.74%+0.01%+17.05% 143B
+1.32%+3.11%+29.39%+32.92% 80.28B
+1.75%-0.53%+7.04%-8.52% 68.33B
-0.54%+1.01%+30.09% - 53.06B
+0.68%-0.44%-16.96%-20.37% 50.05B
-2.81%-4.02%+23.17%-11.43% 39.35B
+0.12%+3.53%+24.65%+44.89% 22.94B
Average +0.05%+0.24%+8.99%+3.06% 112B
Weighted average by Cap. +0.68%+1.66%+16.91%+10.22%

Financials

2027 *2028 *
Net sales 515M 126M 114M 106M 95.39M 180M 11.81B 186M 1.27B 503M 6.34B 472M 462M 20.08B 564M 138M 125M 116M 104M 197M 12.94B 204M 1.39B 551M 6.94B 517M 506M 21.99B
Net income 19.2M 4.69M 4.26M 3.94M 3.55M 6.71M 440M 6.94M 47.33M 18.75M 236M 17.59M 17.22M 748M 33.3M 8.13M 7.39M 6.83M 6.17M 11.64M 764M 12.04M 82.09M 32.53M 410M 30.51M 29.87M 1.3B
Net Debt -64.1M -15.65M -14.22M -13.14M -11.87M -22.4M -1.47B -23.19M -158M -62.61M -789M -58.74M -57.49M -2.5B -63.2M -15.43M -14.02M -12.95M -11.7M -22.08M -1.45B -22.86M -156M -61.73M -778M -57.91M -56.69M -2.46B
Projected Income Statement - Annual - Karex
Logo Karex
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
Employees
2,965
Date Price Change Volume
26-11-17 MYR 0.3800 -1.30% 622,700
26-11-16 MYR 0.3850 -1.28% 158,800
26-11-13 MYR 0.3900 0.00% 589,100
26-11-12 MYR 0.3900 0.00% 1,307,500
26-11-11 MYR 0.3900 -3.70% 307,500
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Karex
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3850MYR
Average target price
0.5833MYR
Spread / Average Target
+51.51%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Karex
  1. Stock Market
  2. Stocks
  3. 5247 Stock